All stock reports

3BBLACKBIO evidence report

Evidence date: 2026-10-01. Research observations only.

What can I do with this stock?

Evaluated 2026-10-02T01:37:53.224812+00:00. Closed-session evidence: 2026-10-01. This is a timestamped assessment, not a live trading feed.

Strategy evidence, instrument feasibility and portfolio suitability are separate. Portfolio suitability has not been assessed.

Today: intraday

Evidence unavailable

No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

  • No current intraday signal and observed quote supplied; daily bars cannot establish a live setup.

Next week: five trading sessions

No qualifying opportunity

No candidate with a primary five-session horizon in the coherent source run.

  • No candidate with a primary five-session horizon in the coherent source run.

Long term: one to three years

Research only

A financial screen alone does not establish an investment recommendation.

  • Financial data quality flags require resolution.
  • A current, source-backed thesis and valuation review is required.

Investment evidence

Statement coverage
FULL_STATEMENTS
Financial source retrieved
2026-08-25T23:17:10.205521+00:00

Metrics

latest_annual_period
2026-03-31
revenue
1419181000.0
net_income
585859000.0
operating_cash_flow
524759000.0
free_cash_flow
269662000.0
total_assets
3779953000.0
total_liabilities
463566000.0
total_equity
3243819000.0
cash
383139000.0
total_debt
Not supplied
revenue_growth
0.4711325757811351
earnings_growth
0.22946085868919686
net_margin
0.41281485589223643
roe
0.18060779593436008
debt_to_equity
Not supplied
cash_conversion
0.8957086944128194
free_cash_flow_margin
0.19001240856522178
trailing_pe
Not supplied
forward_pe
Not supplied
peg_ratio
Not supplied
price_to_book
3.1104198
dividend_yield
Not supplied

Other positional research

No qualifying opportunity

No candidate at another positional horizon in the coherent source run.

  • No candidate at another positional horizon in the coherent source run.
Decision provenance and limitations
Decision ID
decision-f0ec158c62a16629ee050033170424552dbdef451d54e8f1a24d9aacc6f0fb41
Policy
stock-decisions-v1
Evidence bundle hash
743f1ca4a6f8c34a966a1c6c2b318bb0642f1a2d6a80e2989f2d3873da4d8bb4
  • market-brief: a7de4d64fedac164d48cdfb9b4081a4666d7f797f7d9c58da304b329b3a61d3c
  • validation-registry: b1069587129bfc64a703cdf8322d0294692585b7d67f5472593e4164bbb0c3bc
  • financial-statements: a9063b2aebf3760c69a9ace923af4d82fdfbe38186276c43020ad463c4331ffb
  • daily-price: 756b59cdcb24fb66fb7aefe62c85660bdd8986f0e97ac7c044c091d69e6fc60e
  • Conditional research decisions are not orders or personalized position sizes.
  • Scenario payoffs are assumptions, not probabilities or expected returns.
  • A stop price does not guarantee a maximum loss through a gap or illiquidity.

Download the decision evidence as JSON

Evidence briefing

The local language model selected and grouped the following supplied facts.

Overview

Price source verification: VERIFIED. The trailing 5-session price return was 17.13%. The trailing 20-session price return was 11.77%. Average cached traded value over twenty sessions was INR 31,982,682.

Risks

The closing price was -3.72% below its highest close in the available trailing year. Financial data check: balance_sheet_equation: difference=72568000.00. Historical observations do not establish future returns. No verified current news or catalyst evidence is supplied.

Follow Up

The cached financial metric latest annual period is 2026-03-31. The cached financial metric revenue growth is 0.4711325757811351. The cached financial metric net margin is 0.41281485589223643. The cached financial metric roe is 0.18060779593436008. The cached financial metric cash conversion is 0.8957086944128194. The cached financial metric free cash flow margin is 0.19001240856522178.

Cached observations and evidence limits